Sign in

CIK 0001807120

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823929248
Phone
+1 858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Jeffries Sean Chief Operating Officer Grant or award · Stock option (right to buy) +375,000 375,000
2025-01-02 Jeffries Sean Chief Operating Officer Grant or award · Stock option (right to buy) +260,000 260,000
2024-01-02 Jeffries Sean Chief Operating Officer Grant or award · Stock Option (right to buy) +350,000 350,000
2023-02-01 Jeffries Sean Chief Operating Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2022-02-01 Jeffries Sean Chief Operating Officer Grant or award · Stock Option (right to buy) +350,000 350,000
2021-03-30 Jeffries Sean Chief Operating Officer Purchase +3,050 $20.00 $61K 3,050

Page 1 of 1 · 6 trades